check_circleStudy Completed

Contraception, Ovulation Inhibition, Contraceptives, Oral

Study to evaluate efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 24-day regimen

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
1049
Trial Dates
November 2000 - January 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
YAZ (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Multi-center, open, uncontrolled study to investigate the efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol-beta-cyclodextrin clathrate and 3 mg drospirenone in a 24-day regimen for 13 cycles in 1010 healthy female volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A